HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ruth Ann Veach Selected Research

alpha Karyopherins

1/2019Protection from Endotoxin Shock by Selective Targeting of Proinflammatory Signaling to the Nucleus Mediated by Importin Alpha 5.
1/2017Survival, bacterial clearance and thrombocytopenia are improved in polymicrobial sepsis by targeting nuclear transport shuttles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ruth Ann Veach Research Topics

Disease

4Inflammation (Inflammations)
01/2014 - 04/2004
2Sepsis (Septicemia)
01/2019 - 01/2017
2Hypoxia (Hypoxemia)
01/2018 - 01/2012
1Nephrolithiasis
01/2019
1Chronic Renal Insufficiency
01/2019
1Cystinuria
01/2019
1Necrosis
01/2019
1Septic Shock (Toxic Shock Syndrome)
01/2019
1Thrombocytopenia (Thrombopenia)
01/2017
1Multiple Organ Failure (MODS)
01/2017
1Acute Lung Injury
01/2014
1Shock
01/2014
1Pneumonia (Pneumonitis)
01/2014
1Hypercholesterolemia
04/2013
1Fatty Liver
04/2013
1Body Weight (Weight, Body)
04/2013
1Atherosclerosis
04/2013
1Hyperlipidemias (Hyperlipidemia)
04/2013
1Vascular System Injuries
01/2012
1Hemorrhage
01/2012
1Infections
01/2012
1Anthrax
01/2012
1Blindness (Hysterical Blindness)
10/2010
1Autoimmune Diseases (Autoimmune Disease)
10/2010
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2010

Drug/Important Bio-Agent (IBA)

3Transcription Factors (Transcription Factor)IBA
01/2019 - 04/2013
3Virulence Factors (Pathogenicity Factors)IBA
01/2019 - 01/2014
3ChemokinesIBA
01/2014 - 10/2010
3CytokinesIBA
01/2014 - 10/2010
2Karyopherins (Importin)IBA
01/2019 - 01/2014
2alpha KaryopherinsIBA
01/2019 - 01/2017
2NF-kappa B (NF-kB)IBA
01/2017 - 04/2013
2cSN50.1 peptideIBA
01/2014 - 04/2013
2Cell-Penetrating PeptidesIBA
01/2014 - 01/2012
1LipidsIBA
01/2019
1Amino AcidsFDA Link
01/2019
1Sterol Regulatory Element Binding ProteinsIBA
01/2019
1CreatinineIBA
01/2019
1Cystine (L-Cystine)IBA
01/2019
1GalactosamineIBA
01/2019
1Peptides (Polypeptides)IBA
01/2019
1Glutathione (Reduced Glutathione)IBA
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1Cisplatin (Platino)FDA LinkGeneric
01/2018
1Inosine Monophosphate (IMP)IBA
01/2017
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2017
1P-SelectinIBA
01/2017
1E-SelectinIBA
01/2017
1L-SelectinIBA
01/2017
1beta Karyopherins (Importin-beta)IBA
01/2017
1STAT1 Transcription FactorIBA
01/2017
1Interleukin-10 (Interleukin 10)IBA
01/2014
1EndotoxinsIBA
01/2014
1LipopolysaccharidesIBA
01/2014
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2014
1LDL Receptors (LDL Receptor)IBA
04/2013
1Triglycerides (Triacylglycerol)IBA
04/2013
1Blood Glucose (Blood Sugar)IBA
04/2013
1Ciprofloxacin (Cipro)FDA LinkGeneric
01/2012
1InterleukinsIBA
01/2012
1ErythropoietinFDA Link
01/2012
1Biomarkers (Surrogate Marker)IBA
01/2012
1Anti-Bacterial Agents (Antibiotics)IBA
01/2012
1ExotoxinsIBA
01/2012
1Capsules (Microcapsules)IBA
01/2012
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2012
1Insulin (Novolin)FDA Link
10/2010
1staphylococcal enterotoxin BIBA
04/2004

Therapy/Procedure

2Therapeutics
01/2017 - 01/2012
1Immunotherapy
10/2010